CRS-Kiel offers a broad range of clinical research PhaseI/II studies to pharma and biotech clients worldwide. As a commercial CRO, we are located in the University Hospital area of Kiel.

Founded 1992, our experience includes successful FDA inspection in 2002. In close collaboration with the Clinics for Internal Medicine of Kiel’s university hospital we conduct varied study projects for prestige sponsors (top 10 pharmaceutical companies included) from all of the main end-market regions: USA, EU and Asia.